Brown, Lisle/Cummings’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.05M | Sell |
|
|||||
|
2025
Q2 | $3.87M | Buy |
|
|||||
|
2025
Q1 | $3.88M | Buy |
|
|||||
|
2024
Q4 | $4.2M | Sell |
|
|||||
|
2024
Q3 | $5.98M | Buy |
|
|||||
|
2024
Q2 | $6.14M | Sell |
|
|||||
|
2024
Q1 | $5.66M | Sell |
|
|||||
|
2023
Q4 | $4.58M | Buy |
|
|||||
|
2023
Q3 | $3.39M | Buy |
|
|||||
|
2023
Q2 | $2.72M | Sell |
|
|||||
|
2023
Q1 | $2.71M | Sell |
|
|||||
|
2022
Q4 | $2.8M | Hold |
|
|||||
|
2022
Q3 | $2.06M | Sell |
|
|||||
|
2022
Q2 | $2.32M | Sell |
|
|||||
|
2022
Q1 | $2.34M | Buy |
|
|||||
|
2021
Q4 | $2.09M | Buy |
|